Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets

Autor: Ramji, Dipak P., Davies, Thomas S.
Rok vydání: 2015
Předmět:
SREBP
sterol response element binding protein

STAT1
signal transducer and activator of transcription-1

PRR
pattern recognition receptor

Endocrinology
Diabetes and Metabolism

OxLDL
oxidized LDL

TL1A
TNF-like protein 1A

Myocardial Infarction
ICAM-1
intercellular adhesion molecule-1

VCAM-1
vascular cell adhesion molecule-1

Muscle
Smooth
Vascular

miRNA
micro RNA

NLR
NOD-like receptor

MIF
macrophage migration inhibitory factor

VLA4
very late antigen 4

Mice
NPC
Niemann-Pick disease
type C

ERK
extracellular signal-regulated kinase

SR
scavenger receptor

RCT
reverse cholesterol transport

LDL
low-density lipoprotein

SMCs
smooth muscle cells

SR-PSOX
SR that binds phosphatidyl serine and oxidized lipoprotein

Immunology and Allergy
Molecular Targeted Therapy
Survey
TGF
transforming growth factor

SOCS
suppressor of cytokine signaling

TNF
tumor necrosis factor

ABC
ATP-binding cassette

GDF-15
growth differentiation factor-15

TNFSF12
TNF superfamily member 12

eNOS
endothelial nitric oxide synthase

mmLDL
minimally modified LDL

ECM
extracellular matrix

Extracellular Matrix
MMP
matrix metalloproteinase

PECAM-1
platelet endothelial cell adhesion molecule-1

Tregs
regulatory T cells

Cytokines
PAI
plasminogen activator inhibitor

wt
wild type

DCs
dendritic cells

Chemokines
NK
natural killer

CIRT
Cardiovascular Inflammation Reduction Trial

TLR
Toll-like receptor

ECs
endothelial cells

LIGHT
homologous to lymphotoxin
exhibits inducible expression
and competes with HSV glycoprotein D for herpes virus entry mediator
a receptor expressed by T lymphocytes

IL-1RA
IL-1 receptor antagonist

Lipoproteins
Immunology
TWEAK
TNF-related weak inducer of apoptosis

ADRP
adipocyte differentiation related protein

CCR2
CC-chemokine receptor-2

CVD
cardiovascular disease

ER
endoplasmic reticulum

NOD
nucleotide-binding oligomerization domain

ROS
reactive oxygen species

GM-CSF
granulocyte macrophage colony-stimulating factor

TIMP
tissue inhibitor of metalloproteinases

MHC
major histocompatibility complex

Animals
Humans
IFN
interferon

Th
T-helper

Inflammation
Therapeutic avenues
LXR
liver X receptors

TRAIL
TNF-related apoptosis-inducing ligand

Biochemistry
Genetics and Molecular Biology(all)

Macrophages
Fn14
fibroblast growth factor-inducible 14

CANTOS
Canakinumab Anti-inflammatory Thrombosis Outcomes Study

IL-18BP
IL-18 binding protein

CR
chemokine receptor

Atherosclerosis
G-CSF
granulocyte colony-stimulating factor

LDLr
low-density lipoprotein receptor

BMT
bone marrow transplantation

Matrix Metalloproteinases
IL
interleukin

Apo
apolipoprotein

CSF
colony-stimulating factor

M-CSF
macrophage-colony stimulating factor

TF
tissue factor

Endothelium
Vascular

LFA1
lymphocyte function-associated antigen 1

ACAT-1
acyl-CoA acyl transferase-1

NLRP3
NLR family
pyrin domain containing 3
Zdroj: Cytokine & Growth Factor Reviews
ISSN: 1359-6101
DOI: 10.1016/j.cytogfr.2015.04.003
Popis: Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most deaths in westernized societies with numbers increasing at a marked rate in developing countries. The disease is initiated by the activation of the endothelium by various risk factors leading to chemokine-mediated recruitment of immune cells. The uptake of modified lipoproteins by macrophages along with defective cholesterol efflux gives rise to foam cells associated with the fatty streak in the early phase of the disease. As the disease progresses, complex fibrotic plaques are produced as a result of lysis of foam cells, migration and proliferation of vascular smooth muscle cells and continued inflammatory response. Such plaques are stabilized by the extracellular matrix produced by smooth muscle cells and destabilized by matrix metalloproteinase from macrophages. Rupture of unstable plaques and subsequent thrombosis leads to clinical complications such as myocardial infarction. Cytokines are involved in all stages of atherosclerosis and have a profound influence on the pathogenesis of this disease. This review will describe our current understanding of the roles of different cytokines in atherosclerosis together with therapeutic approaches aimed at manipulating their actions.
Databáze: OpenAIRE